Skip to Content

Plecanatide Pregnancy and Breastfeeding Warnings

Plecanatide is also known as: Trulance

Plecanatide Pregnancy Warnings

Animal studies have revealed no effects on embryo-fetal development, fertility or reproductive function in males and females, and fertility in the offspring through maturation with oral administration of this drug during organogenesis at doses much higher than the recommended human dosage. US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.

The manufacturer makes no recommendation regarding use during pregnancy. US FDA pregnancy category: Not assigned. Risk Summary: The available data on use of this drug in pregnant women are not sufficient to inform any drug-associated risks for major birth defects and miscarriage. Comments: Maternal use is not expected to result in fetal exposure to the drug due to negligible systemic drug absorption following oral administration.

See references

Plecanatide Breastfeeding Warnings

No lactation studies in animals have been conducted; however oral administration of this drug to animals during organogenesis through lactation produced no developmental abnormalities or effects on growth, learning and memory, or fertility in the offspring through maturation.

Safety has not been established; benefit should outweigh risk. Excreted into human milk: Unknown Excreted into animal milk: Unknown Comments: The effects in the nursing infant and on milk production are unknown.

See references

References for pregnancy information

  1. "Product Information. Trulance (plecanatide)." Synergy Pharmaceuticals Inc., New York, NY.

References for breastfeeding information

  1. "Product Information. Trulance (plecanatide)." Synergy Pharmaceuticals Inc., New York, NY.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.